Discontinuation report M-RANITIDINE
| Report ID | 124425 |
| Drug Identification Number | 02473542 |
| Brand name | M-RANITIDINE |
| Common or Proper name | Ranitidine |
| Company Name | MANTRA PHARMA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-09-14 |
| Remaining supply date | 2020-09-14 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-09-17 | English | Compare |
| v2 | 2020-09-17 | English | Compare |
| v3 | 2020-09-17 | French | Compare |
| v4 | 2020-09-17 | English | Compare |
| v5 | 2020-09-17 | English | Compare |
| v6 | 2020-09-17 | English | Compare |
| v7 | 2020-09-17 | English | Compare |
| v8 | 2020-09-17 | French | Compare |
| v9 | 2020-09-17 | English | Compare |
| v10 | 2020-09-17 | French | Compare |
| v11 | 2020-09-17 | English | Compare |
| v12 | 2020-09-17 | French | Compare |
Showing 1 to 12 of 12